BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37400498)

  • 1. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.
    Zhang T; Xu D; Liu J; Wang M; Duan LJ; Liu M; Meng H; Zhuang Y; Wang H; Wang Y; Lv M; Zhang Z; Hu J; Shi L; Guo R; Xie X; Liu H; Erickson E; Wang Y; Yu W; Dang F; Guan D; Jiang C; Dai X; Inuzuka H; Yan P; Wang J; Babuta M; Lian G; Tu Z; Miao J; Szabo G; Fong GH; Karnoub AE; Lee YR; Pan L; Kaelin WG; Yuan J; Wei W
    Nat Cell Biol; 2023 Jul; 25(7):950-962. PubMed ID: 37400498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
    Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
    Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting RIPK1 kinase for modulating inflammation in human diseases.
    Li W; Yuan J
    Front Immunol; 2023; 14():1159743. PubMed ID: 36969188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners.
    Li X; Zhang M; Huang X; Liang W; Li G; Lu X; Li Y; Pan H; Shi L; Zhu H; Qian L; Shan B; Yuan J
    Nat Commun; 2020 Dec; 11(1):6364. PubMed ID: 33311474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
    Geng J; Ito Y; Shi L; Amin P; Chu J; Ouchida AT; Mookhtiar AK; Zhao H; Xu D; Shan B; Najafov A; Gao G; Akira S; Yuan J
    Nat Commun; 2017 Aug; 8(1):359. PubMed ID: 28842570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
    Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
    Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
    Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
    J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
    Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis.
    Duprez L; Bertrand MJ; Vanden Berghe T; Dondelinger Y; Festjens N; Vandenabeele P
    J Biol Chem; 2012 Apr; 287(18):14863-72. PubMed ID: 22362767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Regulation of RIPK1 and Necroptosis.
    Xu D; Zou C; Yuan J
    Annu Rev Genet; 2021 Nov; 55():235-263. PubMed ID: 34813352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.
    Ju E; Park KA; Shen HM; Hur GM
    Exp Mol Med; 2022 Sep; 54(9):1401-1411. PubMed ID: 36171264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Suppression of RIPK1-Mediated Signaling.
    Udawatte DJ; Rothman AL
    mBio; 2021 Aug; 12(4):e0172321. PubMed ID: 34372694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
    Dillon CP; Balachandran S
    Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proline hydroxylation at different sites in hypoxia-inducible factor 1α modulates its interactions with the von Hippel-Lindau tumor suppressor protein.
    Qian H; Zou Y; Tang Y; Gong Y; Qian Z; Wei G; Zhang Q
    Phys Chem Chem Phys; 2018 Jul; 20(27):18756-18765. PubMed ID: 29961792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
    Miller F; Kentsis A; Osman R; Pan ZQ
    J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-binding domain in ABIN1 is critical for regulating cell death and inflammation during development.
    Li M; Liu Y; Xu C; Zhao Q; Liu J; Xing M; Li X; Zhang H; Wu X; Wang L; Ou Y; Wu X; Zhao X; Liu H; Qiu L; Li F; Li J; Rong W; Luo Y; Deng J; Wang X; Wang Z; Zhao Y; Lv A; Li Q; Zhang H
    Cell Death Differ; 2022 Oct; 29(10):2034-2045. PubMed ID: 35430614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.